Rapid affinity measurement of protein-protein interactions in a microfluidic platform

被引:23
作者
Salimi-Moosavi, Hossein [1 ]
Rathanaswami, Palaniswami [2 ]
Rajendran, Surendran [1 ]
Toupikov, Mike [3 ]
Hill, John [4 ]
机构
[1] Amgen Inc, Dept Pharmacokinet & Drug Metab, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Therapeut Discovery, Burnaby, BC V5A 1V7, Canada
[3] Amgen Inc, Syst Informat Dept, Thousand Oaks, CA 91320 USA
[4] Amgen Inc, Therapeut Discovery, Seattle, WA 98119 USA
关键词
Binding affinity; Equilibrium binding constant; Equilibrium dissociation constant; GYROS; Gyrolab; KinExA; Antigen-antibody binding; Rapid affinity ranking; KINETIC EXCLUSION ASSAY; ANTIBODY; EQUILIBRIUM; VALIDATION; CONSTANTS;
D O I
10.1016/j.ab.2012.04.023
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid screening method has been developed to determine binding affinities for protein-ligand interactions using the Gyrolab workstation, a commercial microfluidic platform developed to accurately and precisely quantify proteins in solution. This method was particularly suited for assessing the high-affinity interactions that have become typical of therapeutic antibody-antigen systems. Five different commercially available antibodies that bind digoxin and a digoxin-bovine serum albumin (BSA) conjugate with high affinity were rigorously evaluated by this method and by the more conventional kinetic exclusion assay (KinExA) method. Binding parameter values obtained using Gyrolab were similar to those recovered from KinExA. However, the total experimental time for 20 binding affinity titrations, with each titration covering 12 data points in duplicate, took approximately 4 h by the Gyrolab method, which reduced the experimental duration by more than 10-fold when compared with the KinExA method. This rapid binding analysis method has significant applications in the screening and affinity ranking selection of antibodies from a very large pool of candidates spanning a wide range of binding affinities from the low pM to mu M range. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:134 / 141
页数:8
相关论文
共 27 条
[1]  
[Anonymous], 1998, INTRO BOOTSTRAP
[2]   MEASUREMENT AND ANALYSIS OF EQUILIBRIUM BINDING TITRATIONS: A BEGINNER'S GUIDE [J].
Beckett, Dorothy .
METHODS IN ENZYMOLOGY, VOL 488: BIOTHERMODYNAMICS, PT C, 2011, :1-16
[3]  
BEECHEM JM, 1992, METHOD ENZYMOL, V210, P37
[4]   Automated kinetic exclusion assays to quantify protein binding interactions in homogeneous solution [J].
Blake, RC ;
Pavlov, AR ;
Blake, DA .
ANALYTICAL BIOCHEMISTRY, 1999, 272 (02) :123-134
[5]  
Cantor CR., 1980, BIOPHYSICAL CHEM 3, P597
[6]   Kinetic exclusion assay technology: Characterization of molecular interactions [J].
Darling, RJ ;
Brault, PA .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2004, 2 (06) :647-657
[7]   Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface- and solution-based biophysical methods [J].
Day, YSN ;
Baird, CL ;
Rich, RL ;
Myszka, DG .
PROTEIN SCIENCE, 2002, 11 (05) :1017-1025
[8]   Microfluidic analysis of antibody specificity in a compact disk format [J].
Eriksson, Cecilia ;
Agaton, Charlotta ;
Kange, Rikard ;
Sundberg, Marten ;
Nilsson, Peter ;
Ek, Bo ;
Uhlen, Mathias ;
Gustafsson, Magnus ;
Hober, Sophia .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (07) :1568-1574
[9]   Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective [J].
Findlay, JWA ;
Smith, WC ;
Lee, JW ;
Nordblom, GD ;
Das, I ;
DeSilva, BS ;
Khan, MN ;
Bowsher, RR .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 21 (06) :1249-1273
[10]   A microfluidic device for kinetic optimization of protein crystallization and in situ structure determination [J].
Hansen, CL ;
Classen, S ;
Berger, JM ;
Quake, SR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2006, 128 (10) :3142-3143